Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATHE
Alterity Therapeutics LimitedUS flagNASDAQ Capital Market
4.98
USD
+0.24
- -
45.14MMarket Cap

Alterity Therapeutics Limited (ATHE) Stock Split History

Learn about Alterity Therapeutics Limited's most recent 1-for-10 basis stock split on January 09, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Alterity Therapeutics Limited's most recent stock split

Split Date: 2023-01-09
Split Ratio: 1:10
Price Before Split: $0.35
Price After Split: $0.03

Developer API

Get ATHE split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ATHE

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Alterity Therapeutics Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-01-091:10Yes$0.35$0.03
2016-03-241:6Yes$0.51$0.08

About Alterity Therapeutics Limited

Company overview and industry information

Alterity Therapeutics Limited (ATHE) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Alterity Therapeutics Limited Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.